Rick L. Tarleton

14.3k total citations · 1 hit paper
179 papers, 9.9k citations indexed

About

Rick L. Tarleton is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Immunology. According to data from OpenAlex, Rick L. Tarleton has authored 179 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Epidemiology, 125 papers in Public Health, Environmental and Occupational Health and 53 papers in Immunology. Recurrent topics in Rick L. Tarleton's work include Trypanosoma species research and implications (155 papers), Research on Leishmaniasis Studies (119 papers) and Immune Cell Function and Interaction (34 papers). Rick L. Tarleton is often cited by papers focused on Trypanosoma species research and implications (155 papers), Research on Leishmaniasis Studies (119 papers) and Immune Cell Function and Interaction (34 papers). Rick L. Tarleton collaborates with scholars based in United States, Argentina and United Kingdom. Rick L. Tarleton's co-authors include Miriam Postan, Juan M. Bustamante, D. Brent Weatherly, Todd Minning, Duo Peng, Ángel M. Padilla, Kara L. Cummings, Diana L. Martin, Nisha Garg and Ricardo E. Gürtler and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Rick L. Tarleton

178 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kinetoplastids: related protozoan pathogens, different diseases

2008 431 citations Rick L. Tarleton et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Rick L. Tarleton	8.2k	6.6k	2.2k	2.1k	1.9k	179	9.9k
Jeremy C. Mottram	6.7k 0.8×	7.2k 1.1×	1.9k 0.9×	908 0.4×	4.3k 2.2×	263	11.8k
Igor C. Almeida	5.5k 0.7×	3.5k 0.5×	1.8k 0.8×	2.0k 1.0×	3.5k 1.8×	184	9.7k
Étienne Pays	7.8k 1.0×	5.0k 0.8×	1.4k 0.6×	1.4k 0.7×	3.7k 1.9×	177	9.6k
Sérgio Schenkman	5.0k 0.6×	2.7k 0.4×	707 0.3×	1.0k 0.5×	3.3k 1.7×	175	6.6k
Z. Brener	4.7k 0.6×	3.4k 0.5×	1.0k 0.5×	752 0.4×	963 0.5×	141	5.3k
Bianca Zingales	5.2k 0.6×	3.8k 0.6×	1.1k 0.5×	374 0.2×	1.0k 0.5×	100	5.6k
Christine Clayton	7.3k 0.9×	3.9k 0.6×	1.0k 0.5×	1.0k 0.5×	5.3k 2.7×	202	9.6k
Emanuela Handman	4.7k 0.6×	5.8k 0.9×	1.7k 0.8×	3.2k 1.6×	1.9k 1.0×	154	10.2k
Peter J. Myler	4.0k 0.5×	3.4k 0.5×	1.1k 0.5×	578 0.3×	3.7k 1.9×	266	7.2k
Isabelle Coppens	4.1k 0.5×	2.9k 0.4×	4.1k 1.9×	1.2k 0.6×	2.6k 1.3×	162	8.4k

Countries citing papers authored by Rick L. Tarleton

Since Specialization

Citations

This map shows the geographic impact of Rick L. Tarleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick L. Tarleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick L. Tarleton more than expected).

Fields of papers citing papers by Rick L. Tarleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick L. Tarleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick L. Tarleton. The network helps show where Rick L. Tarleton may publish in the future.

Co-authorship network of co-authors of Rick L. Tarleton

This figure shows the co-authorship network connecting the top 25 collaborators of Rick L. Tarleton. A scholar is included among the top collaborators of Rick L. Tarleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick L. Tarleton. Rick L. Tarleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sánchez-Valdéz, Fernando, et al.. (2025). The importance of persistence and dormancy in Trypanosoma cruzi infection and Chagas disease. Current Opinion in Microbiology. 86. 102615–102615. 3 indexed citations

Davila, Edward, Lihua Wei, Carlos A. Rodriguez, et al.. (2024). Domestic Dog Infection with Trypanosoma cruzi from Northern and Southern Regions of Mexico. Vector-Borne and Zoonotic Diseases. 24(8). 510–519. 1 indexed citations

Hamer, Sarah A., et al.. (2024). Positive clinical outcome using a modified dosing regimen of benznidazole in dogs at high risk for infection or acutely infected with Trypanosoma cruzi. Journal of Veterinary Internal Medicine. 38(3). 1725–1729. 4 indexed citations

Rodriguez, Carlos A., et al.. (2023). Validation of a multiplex microsphere immunoassay for detection of antibodies to Trypanosoma cruzi in dogs. Journal of Veterinary Diagnostic Investigation. 35(6). 704–709. 4 indexed citations

Strauch, Eva‐Maria, et al.. (2023). Epitopes in the Glycosylphosphatidylinositol Attachment Signal Peptide of Trypanosoma cruzi Mucin Proteins Generate Robust but Delayed and Nonprotective CD8+ T Cell Responses. The Journal of Immunology. 210(4). 420–430. 6 indexed citations

Bustamante, Juan M., Gregory K. Wilkerson, Carolyn L. Hodo, et al.. (2023). Frequency Variation and Dose Modification of Benznidazole Administration for the Treatment of Trypanosoma cruzi Infection in Mice, Dogs, and Nonhuman Primates. Antimicrobial Agents and Chemotherapy. 67(5). e0013223–e0013223. 12 indexed citations

Padilla, Ángel M., Wei Wang, Tsutomu Akama, et al.. (2022). Discovery of an orally active benzoxaborole prodrug effective in the treatment of Chagas disease in non-human primates. Nature Microbiology. 7(10). 1536–1546. 39 indexed citations

Barrett, Michael P., Dennis E. Kyle, L. David Sibley, Joshua B. Radke, & Rick L. Tarleton. (2019). Protozoan persister-like cells and drug treatment failure. Nature Reviews Microbiology. 17(10). 607–620. 98 indexed citations

Peng, Duo, Samarchith P. Kurup, Phil Y. Yao, Todd Minning, & Rick L. Tarleton. (2014). CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi. mBio. 6(1). e02097–14. 156 indexed citations

10.

Bustamante, Juan M. & Rick L. Tarleton. (2014). Potential new clinical therapies for Chagas disease. Expert Review of Clinical Pharmacology. 7(3). 317–325. 33 indexed citations

11.

Tarleton, Rick L.. (2013). THE ROLE OF IMMUNOLOGY IN COMBATING TRYPANOSOMA CRUZI INFECTION AND CHAGAS DISEASE. SHILAP Revista de lepidopterología. 8 indexed citations

12.

Tarleton, Rick L.. (2011). CHAGAS DISEASE IMPACT AND OPPORTUNITIES: BEYOND THE HISTORICAL DOGMA. Bulletin du Cancer. 96(1). 111–21. 3 indexed citations

13.

Padilla, Ángel M., Laura J. Simpson, & Rick L. Tarleton. (2009). Insufficient TLR Activation Contributes to the Slow Development of CD8+ T Cell Responses in Trypanosoma cruzi Infection. The Journal of Immunology. 183(2). 1245–1252. 60 indexed citations

14.

Albareda, María C., Gabriela C. Olivera, Susana A. Laucella, et al.. (2009). Chronic Human Infection with Trypanosoma cruzi Drives CD4+ T Cells to Immune Senescence. The Journal of Immunology. 183(6). 4103–4108. 80 indexed citations

15.

Bixby, Lisa M. & Rick L. Tarleton. (2008). Stable CD8+ T Cell Memory during Persistent Trypanosoma cruzi Infection. The Journal of Immunology. 181(4). 2644–2650. 47 indexed citations

16.

Martin, Diana L. & Rick L. Tarleton. (2005). Antigen-Specific T Cells Maintain an Effector Memory Phenotype during Persistent Trypanosoma cruzi Infection. The Journal of Immunology. 174(3). 1594–1601. 63 indexed citations

17.

Tarleton, Rick L., et al.. (2003). Cutting Edge: Dysfunctional CD8+ T Cells Reside in Nonlymphoid Tissues During Chronic Trypanosoma cruzi Infection. The Journal of Immunology. 170(5). 2264–2268. 42 indexed citations

18.

Tarleton, Rick L., et al.. (2001). Antigen-Specific Th1 But Not Th2 Cells Provide Protection from Lethal Trypanosoma cruzi Infection in Mice. The Journal of Immunology. 166(7). 4596–4603. 88 indexed citations

19.

Tarleton, Rick L., Michael J. Grusby, & Lei Zhang. (2000). Increased Susceptibility of Stat4-Deficient and Enhanced Resistance in Stat6-Deficient Mice to Infection with Trypanosoma cruzi. The Journal of Immunology. 165(3). 1520–1525. 87 indexed citations

20.

Lappin, Michael R., Craig E. Greene, A. K. Prestwood, Donald L. Dawe, & Rick L. Tarleton. (1989). Diagnosis of recent Toxoplasma gondii infection in cats by use of an enzyme-linked immunosorbent assay for immunoglobulin M. American Journal of Veterinary Research. 50(9). 1580–1585. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact